XML 33 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings (Loss) Per Share
9 Months Ended
Sep. 30, 2017
Earnings Per Share [Abstract]  
(LOSS) EARNINGS PER SHARE
EARNINGS PER SHARE
A computation of (loss) earnings per share and weighted average shares of the Company's common stock outstanding for the three and nine months ended September 30, 2017 and 2016 follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 (amounts in millions, except per share amounts)
2017
 
2016
 
2017
 
2016
Net (loss) income attributable to common stockholders
$
(69.2
)
 
$
104.7

 
$
(154.7
)
 
$
(39.0
)
Numerator adjustments for diluted EPS:
 
 
 
 
 
 
 
Gain on settlement agreement related to Series B Convertible Preferred Stock

 
(103.0
)
 

 
(103.0
)
Gain on amendment of Series B Convertible Preferred Stock

 
(32.9
)
 

 
(32.9
)
Remeasurement adjustment associated with the Preferred Series B redemption liability

 
(6.0
)
 

 
(6.0
)
Income allocated to PDH non-controlling interest

 
(1.5
)
 

 

Net loss attributable to common stockholders for diluted EPS
$
(69.2
)
 
$
(38.7
)
 
$
(154.7
)
 
$
(180.9
)
 
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
286.7

 
234.4

 
285.8

 
231.2

Denominator adjustments for diluted EPS:
 
 
 
 
 
 
 
Assumed conversion related to the amendment of Series B preferred shares

 
17.1

 

 
20.4

Assumed settlement of preferred stock redemption liability

 
5.0

 

 
1.7

Issuable upon conversion of the PDH non-controlling interest

 
8.0

 

 

Share adjustments

 
30.1

 

 
22.1

Dilutive weighted average common shares outstanding
286.7

 
264.5

 
285.8

 
253.3

 
 
 
 
 
 
 
 
(Loss) earnings per share attributable to common stockholders:
 

 
 

 
 

 
 

Basic
$
(0.24
)
 
$
0.45

 
$
(0.54
)
 
$
(0.17
)
Diluted
$
(0.24
)
 
$
(0.15
)
 
$
(0.54
)
 
$
(0.71
)
 
 
 
 
 
 
 
 
Dividends per share paid to common stockholders
$

 
$

 
$

 
$


For the three and nine months ended September 30, 2017 and 2016, the following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because performance targets were not yet achieved for awards contingent upon performance:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 (amounts in thousands)
2017
 
2016
 
2017
 
2016
Shares issuable upon conversion of PDH Common Stock
5,394

 

 
6,299

 
8,023

Shares issuable upon conversion of Series A Preferred Stock
2,000

 
2,000

 
2,000

 
2,000

Shares issuable for the contingent consideration
7,488

 
9,262

 
6,655

 
8,820

Shares issuable upon vesting and exercise of stock options
56

 

 
63

 

Shares issuable upon vesting of RSUs
921

 
186

 
836

 
110

Shares issuable under the ESPP
2

 
1

 
3

 
3

 
15,861

 
11,449

 
15,856

 
18,956